Bacteriocin (hemolysin) of Streptococcus zymogenes.
The sensitivity of Streptococcus faecalis (ATTC 8043) to S. zymogenes X-14 bacteriocin depends greatly on its physiological age. Sensitivity decreases from the mid-log phase on and is completely lost in the stationary phase. The sensitivity of erythrocytes to the hemolytic capacity of the bacteriocin showed considerable species variation. The order of increasing sensitivity was goose < sheep < dog < horse < human < rabbit. However, when red cell stromata were used as inhibitors of hemolysis in a standard system employing rabbit erythrocytes the order of increasing effectiveness was sheep < rabbit < human < horse < goose. When rabbit cells were used in varying concentrations with a constant hemolysin concentration, there was a lag of about 30 min, which for a given hemolysin preparation was constant for all red cell concentrations. Furthermore, the rate of hemolysis increased with increasing red cell concentration. If red cells are held constant and lysin varied, the time to reach half-maximal lysis varies directly with lysin but is not strictly proportional. Bacterial membranes were one to three orders of magnitude more effective than red cell stromata as inhibitors. The order of increasing effectiveness seems to be Escherichia coli < Bacillus megaterium < S. faecalis < Micrococcus lysodeikticus. In addition to membranes, a d-alanine containing glycerol teichoic acid, trypsin in high concentration, and deoxyribonuclease also inhibited hemolysis. Ribonuclease, d-alanine, l-alanine, dl-alanyl-dl-alanine, N-acetyl-d-alanine, N-acetyl-l-alanine did not inhibit hemolysis.
D000818:Animals; D001410:Bacillus megaterium; D001430:Bacteriocins / Q000494:pharmacology*; D001433:Bacteriolysis / Q000187:drug effects; D002462:Cell Membrane; D004285:Dogs; D013293:Enterococcus faecalis / Q000187:drug effects / Q000254:growth & development; D004912:Erythrocytes / Q000187:drug effects; D004926:Escherichia coli; D005777:Geese; D006460:Hemolysin Proteins / Q000494:pharmacology*; D006461:Hemolysis / Q000187:drug effects; D006736:Horses; D006801:Humans; D008837:Micrococcus; D010428:Pentosephosphates / Q000494:pharmacology; D011817:Rabbits; D012756:Sheep; D013291:Streptococcus
D001430:Bacteriocins; D006460:Hemolysin Proteins; D010428:Pentosephosphates